Imperva Announces Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/6/2026
- Stocks close lower as investors eye Mideast talks, earnings
- Trump held multiple undisclosed calls with Fed Chair Warsh, reports say
- Sandisk unveils underwhelming outlook despite AI demand surge; shares slip
- Alphabet taps bond market with sweeping 10-part offering to fuel AI ambitions
- Citi says buy the pullback in memory stocks as upcycle is still in early innings
- Salesforce president Srini Tallapragada steps down, becomes advisor
- EverCommerce names Alex Goor as new CEO, founder steps down
- Sandisk (SNDK) Tops Q4 EPS by $4.66, Offers Guidance
- Crude Inventory Rose 2.5 Million Barrels Last Week - EIA
- AMD shares slide 8% after Musk flags plans to buy Nvidia chips for SpaceX
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Imperial Capital Cuts Price Target on Imperva (IMPV) to $50 Following 2Q; Reiterates Outperform
August 8, 2016 7:19 AM EDTImperial Capital maintained an Outperform rating on Imperva (NYSE: IMPV), and cut the price target to $50.00 (from $55.00), following the company's 2Q earnings report. IMPV reported revenue of $57.9mn and adjusted net loss per share of $0.23. IMPV previously reported preliminary 2Q16 revenue of $57.5-58.0mn and adjusted... More
Wunderlich Securities Downgrades Imperva (IMPV) to Hold
August 5, 2016 8:00 AM EDTWunderlich Securities downgraded Imperva (NYSE: IMPV) from Buy to Hold.
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $45.01 yesterday.
... MoreNeedham & Company Upgrades Imperva (IMPV) to Buy Amid Potential Sale; $64 PT
August 5, 2016 7:27 AM EDTNeedham & Company upgraded Imperva (NYSE: IMPV) from Hold to Buy with a price target of $64.00, as Qatalyst hired for a potential sale.
Analyst Scott Zeller commented, "Our IMPV downgrade post MarQ was based on our lack of confidence that IMPV could achieve... More
Imperva (IMPV) to Review Strategic Alternatives
August 4, 2016 4:43 PM EDTImperva (NYSE: IMPV) announced that its Board of Directors has initiated a comprehensive review of strategic alternatives to enhance shareholder value. The Board has retained Qatalyst Partners as financial advisor and Fenwick & West as legal advisor to assist in the process.
Impervas Board is... More
Imperva (IMPV) Misses Q2 EPS by 6c, FY Guidance Falls Short
August 4, 2016 4:41 PM EDTImperva (NYSE: IMPV) reported Q2 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $57.9 million versus the consensus estimate of $59.11 million.
GUIDANCE:
Imperva sees FY2016 EPS of ($0.82)-($0.78). Imperva sees FY2016 revenue of $248.6-250.6... More
